BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 30761139)

  • 1. Scoring System for Tumor-Infiltrating Lymphocytes and Its Prognostic Value for Gastric Cancer.
    Zhang D; He W; Wu C; Tan Y; He Y; Xu B; Chen L; Li Q; Jiang J
    Front Immunol; 2019; 10():71. PubMed ID: 30761139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer.
    Lu J; Xu Y; Wu Y; Huang XY; Xie JW; Wang JB; Lin JX; Li P; Zheng CH; Huang AM; Huang CM
    BMC Cancer; 2019 Sep; 19(1):920. PubMed ID: 31521128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric cancer.
    Kang BW; Seo AN; Yoon S; Bae HI; Jeon SW; Kwon OK; Chung HY; Yu W; Kang H; Kim JG
    Ann Oncol; 2016 Mar; 27(3):494-501. PubMed ID: 26673353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mismatch Repair Status of Gastric Cancer and Its Association with the Local and Systemic Immune Response.
    Shin SJ; Kim SY; Choi YY; Son T; Cheong JH; Hyung WJ; Noh SH; Park CG; Kim HI
    Oncologist; 2019 Sep; 24(9):e835-e844. PubMed ID: 30894409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy.
    Tokito T; Azuma K; Kawahara A; Ishii H; Yamada K; Matsuo N; Kinoshita T; Mizukami N; Ono H; Kage M; Hoshino T
    Eur J Cancer; 2016 Mar; 55():7-14. PubMed ID: 26771872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer.
    Qu JL; Qu XJ; Li Z; Zhang JD; Liu J; Teng YE; Jin B; Zhao MF; Yu P; Shi J; Fu LY; Wang ZN; Liu YP
    PLoS One; 2015; 10(6):e0128540. PubMed ID: 26075713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of CD11c indicates favorable prognosis in patients with gastric cancer.
    Wang Y; Xu B; Hu WW; Chen LJ; Wu CP; Lu BF; Shen YP; Jiang JT
    World J Gastroenterol; 2015 Aug; 21(31):9403-12. PubMed ID: 26309367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
    Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
    World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of tumor-infiltrating lymphocytes within the tumor microenvironment in gastric cancer.
    Pereira MA; Ramos MFKP; Cardili L; de Moraes RDR; Dias AR; Szor DJ; Zilberstein B; Alves VAF; de Mello ES; Ribeiro U
    J Gastrointest Surg; 2024 Feb; 28(2):151-157. PubMed ID: 38445936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-L1 expression and tumor infiltrating PD-1+ lymphocytes associated with outcome in HER2+ breast cancer patients.
    Tsang JY; Au WL; Lo KY; Ni YB; Hlaing T; Hu J; Chan SK; Chan KF; Cheung SY; Tse GM
    Breast Cancer Res Treat; 2017 Feb; 162(1):19-30. PubMed ID: 28058578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline Peripheral Blood Leukocytosis Is Negatively Correlated With T-Cell Infiltration Predicting Worse Outcome in Colorectal Cancers.
    Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
    Front Immunol; 2018; 9():2354. PubMed ID: 30369930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the Chemokine Receptor CXCR3 Correlates with Dendritic Cell Recruitment and Prognosis in Gastric Cancer.
    Chen F; Yin S; Niu L; Luo J; Wang B; Xu Z; Yang G
    Genet Test Mol Biomarkers; 2018 Jan; 22(1):35-42. PubMed ID: 29266971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Low Densities of FoxP3
    Cavalleri T; Bianchi P; Basso G; Celesti G; Grizzi F; Bossi P; Greco L; Pitrone C; Valtorta E; Mauri G; Truini M; Dall'Olio FG; Brandi G; Sartore-Bianchi A; Ricciardiello L; Torri V; Rimassa L; Siena S; Mantovani A; Malesci A; Laghi L;
    Cancer Immunol Res; 2019 May; 7(5):751-758. PubMed ID: 30804005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.
    Feng W; Li Y; Shen L; Cai XW; Zhu ZF; Chang JH; Xiang JQ; Zhang YW; Chen HQ; Fu XL
    Oncotarget; 2016 Feb; 7(6):7227-40. PubMed ID: 26811495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse distribution of tumor-infiltrating lymphocytes is a marker for better prognosis and chemotherapeutic effect in triple-negative breast cancer.
    Hida AI; Watanabe T; Sagara Y; Kashiwaba M; Sagara Y; Aogi K; Ohi Y; Tanimoto A
    Breast Cancer Res Treat; 2019 Nov; 178(2):283-294. PubMed ID: 31402409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers.
    Kim KJ; Lee KS; Cho HJ; Kim YH; Yang HK; Kim WH; Kang GH
    Hum Pathol; 2014 Feb; 45(2):285-93. PubMed ID: 24331841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients.
    Koh J; Ock CY; Kim JW; Nam SK; Kwak Y; Yun S; Ahn SH; Park DJ; Kim HH; Kim WH; Lee HS
    Oncotarget; 2017 Apr; 8(16):26356-26367. PubMed ID: 28412752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer.
    Hu H; Li C; Cai S; Zhu C; Tian Y; Zheng J; Hu J; Chen C; Liu W
    Hepatogastroenterology; 2014; 61(133):1478-82. PubMed ID: 25436328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
    Tomsová M; Melichar B; Sedláková I; Steiner I
    Gynecol Oncol; 2008 Feb; 108(2):415-20. PubMed ID: 18037158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance and prognostic value of Triosephosphate isomerase expression in gastric cancer.
    Chen T; Huang Z; Tian Y; Lin B; He R; Wang H; Ouyang P; Chen H; Wu L
    Medicine (Baltimore); 2017 May; 96(19):e6865. PubMed ID: 28489783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.